News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
When stomach cancer survivor becomes expert
Despite encountering more than her share of health challenges, 92-year-old Delva Walker has the most positive outlook you are ever likely to encounter.… Read more
-
Charlie’s story – Grieving couple’s mission to end necrotising enterocolitis
Through their grief one young couple has joined Hudson Institute researchers in a bold effort to find out more about the disease that killed their first child, and to end necrotising enterocolitis.… Read more
-
Young women launch into science
In a week of opening eyes and broadening minds, a dozen young women have fed their passion for science, thanks to Hudson Institue mentors.… Read more
-
Gene link to female infertility
Loss of a single gene could be enough to cause female infertility, with new research identifying the crucial role it plays in egg production.… Read more
-
Hudson CEO appointed AAMRI President
Hudson Institute has cemented its position among Australia’s medical research leaders, with Director and CEO, Professor Elizabeth Hartland becoming President of the peak industry body.… Read more
-
Strength in diversity – computing healthy microbiome relationships
The more diverse species in your gut, the better it is for your health, but researchers have now found a way to determine which species are important and how they interact to create a healthy microbiome.… Read more
-
Cerebral palsy community consulted on stem cell treatment
Exploring the boundaries of stem cell therapy: Scientists consulted the cerebral palsy community to understand their perspectives.… Read more
-
Setting the PACE – Primary Aldosteronism research boost
A hidden cause of disease for more than half a million Australians – and the researchers pioneering its detection and treatment – have been recognised in a big way, with Hudson Institute to be home to the new NHMRC Primary Aldosteronism Centre of Excellence (PACE).… Read more
-
Cancer drug limits COVID inflammation
A cancer drug could play an important role in limiting the damaging effects of lung disease inflammation in COVID-19 patients, thanks to new research at Hudson Institute.… Read more
-
Delivering hope: anti-inflammatory drug trial for preterm babies
When baby Blessing was born at just 25 weeks, her parents joined a medical trial they hope will benefit all preterm babies.… Read more